| Value | ₹116.0 Cr |
|---|
BSE filing, NSE: ZEEL. Summary written from the filing by ALFA Finder's alert engine.
Zee Entertainment Enterprises Ltd: key numbers
- Share price
- ₹66.40
- Market cap
- ₹6,378 Cr
- Revenue (annual)
- ₹8,099 Cr
- Net profit (annual)
- ₹273.1 Cr
- P/E (TTM)
- 36.0×Sector 28.1×
- Promoter holding
- 3.99%+0.00% QoQ
- FII holding
- 18.08%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Zee Entertainment Enterprises Ltd
All →Zee Entertainment Enterprises Earnings Call Transcript: Key Takeaways
Q2 FY27 revenue rose 13% YoY to ₹22,246 Mn on digital and FIFA, but EBITDA margin fell to 3.2% (7.4% a year ago) and PAT fell 40%.
Zee Entertainment Enterprises Other Announcement
Zee Entertainment updated its authorised KMP list for Reg 30 disclosures, effective 2 November 2026, after a Company Secretary change. No money or business event is involved.
Zee Entertainment Enterprises Management Change
Zee Entertainment appointed Sangeeta Shetty as Chief Compliance Officer and Company Secretary effective 2 November 2026, replacing Ashish Agarwal who resigned. No monetary value is involved.
Zee Entertainment Enterprises Results Update
Zee Entertainment filed an earnings release for Q2 FY27 on unaudited standalone and consolidated results. Operating revenue rose 13% YoY to Rs 22,246 Mn with EBITDA of Rs 708 Mn.
Zee Entertainment Enterprises Q2 FY27 Results: Net Profit ₹45.6 Cr, Down 40.4% YoY
Zee Entertainment Enterprises Ltd reported revenue from operations of ₹2,225 Cr (+13.0% YoY) and net profit of ₹45.6 Cr (-40.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹45.6 Cr · -40.4% YoY
Zee Entertainment Enterprises Board Meeting Date
Zee Entertainment scheduled a board meeting for 30 October 2026 to consider Q1 standalone and consolidated unaudited results. The trading window stays closed until 48 hours after the results.
Other acquisition announcements
All →Kalpataru Acquisition Worth ₹52.55 Cr
Kalpataru's subsidiary KPL approved acquiring 16.67% of step-down subsidiaries AREPL and AREDPL for ₹52.55 Crore. This makes them wholly owned, giving Kalpataru 100% of Kalpataru Parkcity project cash flows at Thane.
- Value
- ₹52.55 Cr
- Execution
- 60 days, subject to receipt of requisite approvals
Zydus Lifesciences Acquisition Worth ₹84 Cr
Zydus Lifesciences acquired Sterling Biotech's API business for Rs. 84 Crore via slump sale. The deal covers fermentation-based API products and is completed.
- Value
- ₹84.00 Cr
Zydus Lifesciences Acquisition Worth ₹167 Cr
Zydus Lifesciences completed acquisition of Sterling Biotech's API business for Rs. 167 Crore. The slump sale of fermentation-based API products strengthens its manufacturing portfolio.
- Value
- ₹167.0 Cr
Zydus Lifesciences Acquisition
Zydus Lifesciences completed its acquisition of Sterling Biotech's API business under a September 2024 Business Transfer Agreement. No transaction value was disclosed in this filing.
Arvaya Healthcare Acquisition
Arvaya Healthcare completed the acquisition of 100% equity in Sushodha Institute of Gastroenterology Private Limited on 1 November 2026. The target is now a wholly-owned subsidiary, with no consideration amount disclosed.
Affle 3I Acquisition Worth ₹3,990 Cr
Affle 3i's step-down subsidiary will acquire Perion Network in an all-cash deal valued at about ₹3,990 Crore. Closing is expected in early 2027.
- Value
- ₹3,990 Cr
- Execution
- Expected to close in early 2027